Showing Results for: “diabetes exercise”

The American Diabetes Association ® applauds the Washington governor and legislature for passing SB 6087 Recently, Washington Governor Jay Inslee signed into law American Diabetes Association (ADA)-supported legislation capping monthly copayments for insulin at $100 for a 30-day supply. Senate Bill 6087 (SB 6087) requires insulin to be covered by state regulated commercial health insurance plans and state employee plans without being subject to a deductible. In addition, any cost sharing the individual is required to pay by their policy will be applied toward their deductible. The bill also

The American Diabetes Association ® applauds the Virginia governor and legislature for passing HB 66 Recently, House Bill 66 (HB 66) was signed into law by Virginia Governor Ralph Northam. This legislation, which was supported by the American Diabetes Association (ADA), will limit cost sharing to $50 per 30-day supply of insulin for those with state-regulated commercial insurance. LaShawn McIver, MD, MPH, Senior Vice President of Government Affairs & Advocacy for the ADA, issued the following statement: “Insulin has tripled in price between 2002 and 2013, forcing far too many Americans to make

The American Diabetes Association ® applauds the New York governor and legislature for passing insulin co-pay cap in state budget Recently, New York State Senate Bill 7506-B (S7506B) was signed into law by Governor Andrew Cuomo as part of the 2020 New York State Budget. A provision in the law limits cost sharing for insulin to $100 per 30-day supply for those with state-regulated commercial insurance, a measure supported by the American Diabetes Association (ADA). The new law will take effect as plans are issued or renewed in the upcoming year. LaShawn McIver, MD, MPH, Senior Vice President of

The American Diabetes Association ® applauds the West Virginia governor and legislature for passing HB 4543 Recently, House Bill 4543 (HB 4543) was signed into law by West Virginia Governor Jim Justice. This legislation, which was supported by the American Diabetes Association (ADA), will limit cost sharing to $100 per 30-day supply of insulin for those with state-regulated commercial insurance. The new law also provides coverage for diabetes self-management education (DSME) and provides a new coverage mandate for blood glucose monitors, monitor supplies, insulin, injection aids, syringes

The health and safety of those we serve continues to be the top priority of the American Diabetes Association (ADA). At this time, the World Health Organization (WHO) has made the assessment that COVID-19 can be characterized as a pandemic. We agree with The Centers for Disease Control and Prevention (CDC) that COVID-19 (coronavirus) is a serious public health threat—and older adults and people with serious chronic medical conditions, including diabetes, are at a higher risk of getting very sick from it. The CDC reports that people in places where ongoing community spread of the virus that

The ADA has resources for people with diabetes at diabetes.org/coronoavirus The CDC has determined that COVID-19 is a serious public health threat. In general people with diabetes face greater risks of complications when dealing with viral infections like flu, and that is likely to be true with COVID-19. Recommended safety precautions are the same as for flu, such as frequent hand washing and covering coughs and sneezes with a tissue. The CDC does not recommend the use of face masks by people who are not infected. The American Diabetes Association (ADA) encourages people with diabetes to

In conjunction with a session at the Academy of Nutrition and Dietetics Food & Nutrition Conference & Expo (FNCE), the American Diabetes Association (ADA) is releasing a new resource to help people living with diabetes answer one of the most common and challenging questions: ‘What can I eat?’ The new resource is free and available to download here . “As a dietitian working with patients living with type 2 diabetes, I saw firsthand how critical the food we eat is in managing diabetes,” said Shamera Robinson, MPH, RDN, Associate Director of Nutrition for the ADA. “Unfortunately, there is a lot

Ten grants from the American Diabetes Association and the American Heart Association’s joint initiative aiming to decrease heart disease and stroke among people living with Type 2 diabetes. The American Diabetes Association ® and the American Heart Association ® have awarded grants to 10 community organizations to help people living with Type 2 diabetes lower their risk for cardiovascular diseases like heart attack, heart failure and stroke. The community grants are part of the leading health non-profits’ joint Know Diabetes by Heart ™ initiative which seeks to reduce cardiovascular events and

Today, the American Diabetes Association® (ADA) released a guidance statement on the use of compounded GLP-1 RA (glucagon-like peptide-1 receptor agonist) and dual GIP/GLP-1 RA (glucose-dependent insulinotropic polypeptide and GLP-1 RA) medication classes. The statement recommends against using non-Food & Drug Administration (FDA)-approved compounded GLP-1 and dual GIP/GLP-1 RA products due to uncertainty about their content, safety, quality, and effectiveness. GLP-1 RA and dual GIP and GLP-1 RA medication classes are recommended by the ADA’s Standards of Care in Diabetes for use in people

On Thursday, March 28, the American Diabetes Association® (ADA), along with hundreds of people living with diabetes, caregivers, health care providers, and researchers will meet with members of Congress to ask them to make diabetes a national priority. Diabetes Advocates will heighten awareness around the everyday reality of diabetes, the impact of the rising cost of insulin, and the need for increased federal funding for diabetes research and programs during the ADA’s 2019 Call to Congress event. On behalf of the more than 30 million Americans living with diabetes, they are scheduled to